SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015099
Filing Date
2021-11-09
Accepted
2021-11-08 17:46:50
Documents
80
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akya-20210930x10q.htm   iXBRL 10-Q 2594600
2 EX-31.1 akya-20210930xex31d1.htm EX-31.1 14850
3 EX-31.2 akya-20210930xex31d2.htm EX-31.2 14907
4 EX-32.1 akya-20210930xex32d1.htm EX-32.1 6816
5 EX-32.2 akya-20210930xex32d2.htm EX-32.2 7832
  Complete submission text file 0001558370-21-015099.txt   9356447

Data Files

Seq Description Document Type Size
6 EX-101.SCH akya-20210930.xsd EX-101.SCH 55588
7 EX-101.CAL akya-20210930_cal.xml EX-101.CAL 58595
8 EX-101.DEF akya-20210930_def.xml EX-101.DEF 260420
9 EX-101.LAB akya-20210930_lab.xml EX-101.LAB 531312
10 EX-101.PRE akya-20210930_pre.xml EX-101.PRE 419941
11 EXTRACTED XBRL INSTANCE DOCUMENT akya-20210930x10q_htm.xml XML 1702291
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40344 | Film No.: 211389153
SIC: 3826 Laboratory Analytical Instruments